Stay updated on ALD403 in Chronic Migraine Clinical Trial

Sign up to get notified when there's something new on the ALD403 in Chronic Migraine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALD403 in Chronic Migraine Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:36:44.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the data related to ALD403 in the prevention of migraine headache in chronic migraineurs, specifically in a Phase 2 clinical trial evaluating the efficacy, safety, and pharmacokinetics of ALD403 administered intravenously.
    Difference
    0.1%
    Check dated 2024-06-06T14:29:18.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants, specifying the diagnosis and history of chronic migraine required, as well as the conditions and treatments that would exclude someone from the study.
    Difference
    17%
    Check dated 2024-05-22T21:11:13.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:31:12.000Z thumbnail image

Stay in the know with updates to ALD403 in Chronic Migraine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALD403 in Chronic Migraine Clinical Trial page.